A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer Cachexia

Clinical trial NCT07243379 · RECRUITING

Trial details

NCT number: NCT07243379
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Clinical Characteristics and Treatment Outcomes of Malignant Tumor Cachexia Multicenter Observational Study

Start date: 2025-09-25
Primary completion: 2026-12-31
Enrollment: 495

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.